These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Multi-institutional validation of the ability of preoperative hydronephrosis to predict advanced pathologic tumor stage in upper-tract urothelial carcinoma. Messer JC; Terrell JD; Herman MP; Ng CK; Scherr DS; Scoll B; Boorjian SA; Uzzo RG; Wille M; Eggener SE; Lucas SM; Lotan Y; Shariat SF; Raman JD Urol Oncol; 2013 Aug; 31(6):904-8. PubMed ID: 21906967 [TBL] [Abstract][Full Text] [Related]
4. Fluorescence in situ hybridization (FISH) in the diagnosis of bladder and upper tract urothelial carcinoma: the largest single-institution experience to date. Gomella LG; Mann MJ; Cleary RC; Hubosky SG; Bagley DH; Thumar AB; McCue PA; Lallas CD; Trabulsi EJ Can J Urol; 2017 Feb; 24(1):8620-8626. PubMed ID: 28263126 [TBL] [Abstract][Full Text] [Related]
5. Does urinary cytology have a role in haematuria investigations? Tan WS; Sarpong R; Khetrapal P; Rodney S; Mostafid H; Cresswell J; Watson D; Rane A; Hicks J; Hellawell G; Davies M; Srirangam SJ; Dawson L; Payne D; Williams N; Brew-Graves C; Feber A; Kelly JD; BJU Int; 2019 Jan; 123(1):74-81. PubMed ID: 30003675 [TBL] [Abstract][Full Text] [Related]
6. Usefulness of NMP22 as an adjunct to a typical urine cytology and low-grade urothelial carcinoma. Arora VK; Sarungbam J; Bhatia A; Singh N; Agrawal V; Aggarwal S Diagn Cytopathol; 2010 Nov; 38(11):788-90. PubMed ID: 20014314 [TBL] [Abstract][Full Text] [Related]
7. Clinical application of NMP22 in the management of transitional cell carcinoma of the bladder. Sawczuk IS; Bagiella E; Sawczuk AT; Yun EJ Cancer Detect Prev; 2000; 24(4):364-8. PubMed ID: 11059567 [TBL] [Abstract][Full Text] [Related]
8. Microsatellite analysis of voided-urine samples for surveillance of low-grade non-muscle-invasive urothelial carcinoma: feasibility and clinical utility in a prospective multicenter study (Cost-Effectiveness of Follow-Up of Urinary Bladder Cancer trial [CEFUB]). van der Aa MN; Zwarthoff EC; Steyerberg EW; Boogaard MW; Nijsen Y; van der Keur KA; van Exsel AJ; Kirkels WJ; Bangma C; van der Kwast TH Eur Urol; 2009 Mar; 55(3):659-67. PubMed ID: 18501499 [TBL] [Abstract][Full Text] [Related]
9. Multitarget fluorescence in situ hybridization assay detects transitional cell carcinoma in the majority of patients with bladder cancer and atypical or negative urine cytology. Skacel M; Fahmy M; Brainard JA; Pettay JD; Biscotti CV; Liou LS; Procop GW; Jones JS; Ulchaker J; Zippe CD; Tubbs RR J Urol; 2003 Jun; 169(6):2101-5. PubMed ID: 12771727 [TBL] [Abstract][Full Text] [Related]
10. Immunocyt test improves the diagnostic accuracy of urinary cytology: results of a French multicenter study. Pfister C; Chautard D; Devonec M; Perrin P; Chopin D; Rischmann P; Bouchot O; Beurton D; Coulange C; Rambeaud JJ J Urol; 2003 Mar; 169(3):921-4. PubMed ID: 12576813 [TBL] [Abstract][Full Text] [Related]
11. Urinary level of nuclear matrix protein 22 in the diagnosis of bladder cancer: experience with 130 patients with biopsy confirmed tumor. Casella R; Huber P; Blöchlinger A; Stoffel F; Dalquen P; Gasser TC; Lehmann K J Urol; 2000 Dec; 164(6):1926-8. PubMed ID: 11061883 [TBL] [Abstract][Full Text] [Related]
12. Immunocyt and the HA-HAase urine tests for the detection of bladder cancer: a side-by-side comparison. Hautmann S; Toma M; Lorenzo Gomez MF; Friedrich MG; Jaekel T; Michl U; Schroeder GL; Huland H; Juenemann KP; Lokeshwar VB Eur Urol; 2004 Oct; 46(4):466-71. PubMed ID: 15363562 [TBL] [Abstract][Full Text] [Related]
13. Pathologic features of bladder tumors after nephroureterectomy or segmental ureterectomy for upper urinary tract transitional cell carcinoma. Raman JD; Sosa RE; Vaughan ED; Scherr DS Urology; 2007 Feb; 69(2):251-4. PubMed ID: 17320658 [TBL] [Abstract][Full Text] [Related]
14. Urine cytology in bladder tumors. Zein TA; Milad MF Int Surg; 1991; 76(1):52-4. PubMed ID: 2045253 [TBL] [Abstract][Full Text] [Related]
15. Nomograms including nuclear matrix protein 22 for prediction of disease recurrence and progression in patients with Ta, T1 or CIS transitional cell carcinoma of the bladder. Shariat SF; Zippe C; Lüdecke G; Boman H; Sanchez-Carbayo M; Casella R; Mian C; Friedrich MG; Eissa S; Akaza H; Sawczuk I; Serretta V; Huland H; Hedelin H; Rupesh R; Miyanaga N; Sagalowsky AI; Wians F; Roehrborn CG; Lotan Y; Perrotte P; Benayoun S; Marberger MJ; Karakiewicz PI J Urol; 2005 May; 173(5):1518-25. PubMed ID: 15821471 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of urine tumor-associated trypsin inhibitor, CYFRA 21-1, and urinary bladder cancer antigen for detection of high-grade bladder carcinoma. Gkialas I; Papadopoulos G; Iordanidou L; Stathouros G; Tzavara C; Gregorakis A; Lykourinas M Urology; 2008 Nov; 72(5):1159-63. PubMed ID: 18514770 [TBL] [Abstract][Full Text] [Related]
17. Institutional variability in the accuracy of urinary cytology for predicting recurrence of transitional cell carcinoma of the bladder. Karakiewicz PI; Benayoun S; Zippe C; Lüdecke G; Boman H; Sanchez-Carbayo M; Casella R; Mian C; Friedrich MG; Eissa S; Akaza H; Huland H; Hedelin H; Rupesh R; Miyanaga N; Sagalowsky AI; Marberger MJ; Shariat SF BJU Int; 2006 May; 97(5):997-1001. PubMed ID: 16542342 [TBL] [Abstract][Full Text] [Related]
18. Clinical under staging of high risk nonmuscle invasive urothelial carcinoma treated with radical cystectomy. Dutta SC; Smith JA; Shappell SB; Coffey CS; Chang SS; Cookson MS J Urol; 2001 Aug; 166(2):490-3. PubMed ID: 11458053 [TBL] [Abstract][Full Text] [Related]
19. Voided urine fluorescence in situ hybridization testing for upper tract urothelial carcinoma surveillance. Johannes JR; Nelson E; Bibbo M; Bagley DH J Urol; 2010 Sep; 184(3):879-82. PubMed ID: 20643443 [TBL] [Abstract][Full Text] [Related]
20. Risk stratification for bladder tumor recurrence, stage and grade by urinary nuclear matrix protein 22 and cytology. Shariat SF; Casella R; Wians FH; Ashfaq R; Balko J; Sulser T; Gasser TC; Sagalowsky AI Eur Urol; 2004 Mar; 45(3):304-13; author reply 313. PubMed ID: 15036675 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]